Work

Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in anIn VitroAssay

Year: 2018

Type: article

Abstract: Tuberculosis is the ninth-leading cause of death worldwide. Treatment success is approximately 80% for susceptible strains and decreases to 30% for extensively resistant strains.

Source: Antimicrobial Agents and Chemotherapy

DOI: 10.1128/aac.00856-18

Authors: Carolina de Miranda Silva, Amirhossein Hajihosseini, Jenny Myrick, Jocelyn Nole, Arnold Louie, Stephan Schmidt, George L. Drusano

Institution: University of Florida

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Award: Optimizing Combination Therapy to Accelerate Clinical Cure of Tuberculosis

OpenAlex ID: W2806629668

FWCI: 3.023

Cites: 23

Cited by: 26

Related to: 10